A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 111 (4) , 743-749
- https://doi.org/10.1067/mai.2003.1387
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Possible involvement of mast‐cell activation in aspirin provocation of aspirin‐induced asthmaAllergy, 2001
- 15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathwayProceedings of the National Academy of Sciences, 2000
- Adventitial Mast Cells Connect With Sensory Nerve Fibers in Atherosclerotic Coronary ArteriesCirculation, 2000
- Prostaglandin D 2 as a Mediator of Allergic AsthmaScience, 2000
- Association Between Myocardial Infarction and the Mast Cells in the Adventitia of the Infarct-Related Coronary ArteryCirculation, 1999
- Urinary excretion of inflammatory mediators during allergen‐induced early and late phase asthmatic reactionsClinical and Experimental Allergy, 1998
- Increased urinary excretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstructionJournal of Allergy and Clinical Immunology, 1996
- Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responsesJournal of Allergy and Clinical Immunology, 1988
- Release of tryptase together with histamine during the immediate cutaneous response to allergenJournal of Allergy and Clinical Immunology, 1987
- Release of Prostaglandin D2into Human Airways during Acute Antigen ChallengeNew England Journal of Medicine, 1986